BriaCell Therapeutics Corp.
Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.
BCTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- CA10778Y3007 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
- Website:
- https://briacell.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing targeted cellular immunotherapies to activate the patient's immune system against cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™ has received FDA Fast Track designation and has shown efficacy in heavily pre-treated patients, including those with central nervous system metastases. The company is also advancing its next-generation Bria-OTS™ platform, which provides personalized, off-the-shelf treatments matched to a patient's HLA type. The Bria-OTS™ platform is being evaluated in a Phase 1/2 clinical trial for multiple cancers, including breast, prostate, and lung cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all BriaCell Therapeutics Corp. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BriaCell Therapeutics Corp.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BriaCell Therapeutics Corp. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
